From: Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B
Cell Line
IC50 (nM)
GrB-Fc-4D5
GrB(S195A)-Fc-4D5
SKBR3
43
1494
MDA-MB-453
22
2294
A-549
49
887
MDA-MB-231
40
685